Imipramine Pamoate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Imipramine Pamoate.
Product ID | 68180-317_2b254d48-4c9c-4f27-96ba-f551f4a34d59 |
NDC | 68180-317 |
Product Type | Human Prescription Drug |
Proprietary Name | Imipramine Pamoate |
Generic Name | Imipramine Pamoate |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2010-04-16 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA090444 |
Labeler Name | Lupin Pharmaceuticals, Inc. |
Substance Name | IMIPRAMINE PAMOATE |
Active Ingredient Strength | 150 mg/1 |
Pharm Classes | Tricyclic Antidepressant [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2010-04-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA090444 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-04-16 |
Marketing Category | ANDA |
Application Number | ANDA090444 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-04-16 |
Ingredient | Strength |
---|---|
IMIPRAMINE PAMOATE | 150 mg/1 |
SPL SET ID: | d1dde497-1889-4424-af18-da7ca6459cf3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0054-0273 | Imipramine Pamoate | Imipramine Pamoate |
0054-0274 | Imipramine Pamoate | Imipramine Pamoate |
0054-0275 | Imipramine Pamoate | Imipramine Pamoate |
0054-0276 | Imipramine Pamoate | Imipramine Pamoate |
57297-314 | Imipramine Pamoate | Imipramine Pamoate |
57297-315 | Imipramine Pamoate | Imipramine Pamoate |
57297-316 | Imipramine Pamoate | Imipramine Pamoate |
57297-317 | Imipramine Pamoate | Imipramine Pamoate |
68180-314 | Imipramine Pamoate | Imipramine Pamoate |
68180-315 | Imipramine Pamoate | Imipramine Pamoate |
68180-316 | Imipramine Pamoate | Imipramine Pamoate |
68180-317 | Imipramine Pamoate | Imipramine Pamoate |